PDL BioPharma Inc (NASDAQ:PDLI)

2.37
Delayed Data
As of Jun 22
 -0.05 / -2.07%
Today’s Change
2.15
Today|||52-Week Range
3.55
-13.50%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
AssetsCash349.4M510.1M527.3M405.1M
 
 
 
 
 
Short Term Investment Cash35.1M160.7M17.2M-122.2M
 
 
 
 
 
Cash & Short Term Investments435.3M516.5M532.1M405.1M
 
 
 
 
 
 
ReceivablesReceivables83.2M75.0M84.8M78.5M
 
 
 
 
 
 
InventoriesInventories11.5M12.2M9.1M14.0M
 
 
 
 
 
 
Current AssetsOther Current Assets6.9M9.5M14.4M13.4M
 
 
 
 
 
Current Assets536.8M613.2M640.4M510.9M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross----18.7M--
 
 
Depreciation-----11.5M--
 
 
Intangible Assets571.3M574.0M565.0M554.9M
 
 
 
 
 
Other Assets573.1M575.2M569.3M557.7M
 
 
 
 
 
Total Assets1.3B1.2B1.2B1.1B
 
 
 
 
 
 
LiabilitiesAccounts Payable10.4M10.4M19.8M10.0M
 
 
 
 
 
Short Term Debt123.8M124.9M126.1M0.00
 
 
 
 
Accrued Expenses25.3M23.7M27.6M26.1M
 
 
 
 
 
Other Current Liabilities119.9M43.2M39.8M34.9M
 
 
 
 
 
Other Liabilities276.3M194.1M193.1M51.0M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt114.0M115.7M117.4M119.2M
 
 
 
 
 
Deferred Taxes-18.2M-6.2M-1.2M-746.0K
 
 
 
 
 
Other Liabilities14.9M15.5M54.8M54.4M
 
 
 
 
 
Total Liabilities483.2M400.9M397.2M257.3M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity818.8M823.0M845.9M843.1M
 
 
 
 
 
Total Shareholder Equity818.8M823.0M845.9M843.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding154.1M154.3M153.8M152.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.